Table 4.
Unadjusted and mutually adjusted rate ratios (RR) for dysplastic recurrence by baseline characteristics following complete eradication of intestinal metaplasia (CE-IM) among patients with at least one surveillance endoscopy after achieving CE-IM.
| Characteristic | Recur - N (%) | No Recurrence - N (%) | Unadjusted RR (95% CL) | Adjusted RR (95% CL) |
|---|---|---|---|---|
| Age (years) - 25 to 60 | 3 (10.7) | 31 (16.8) | 0.63 (0.15 – 1.86) | 0.77 (0.17 – 2.42) |
| - 61 to 80 | 19 (67.9) | 126 (68.1) | Ref. | Ref. |
| - 81 to 101 | 6 (21.4) | 28 (15.1) | 1.28 (0.47 – 3.03) | 1.67 (0.56 – 4.39) |
| BMI (mg/kg2) - Normal (18.5 – 24.9) | 3 (14.3) | 25 (13.4) | Ref. | Ref. |
| - Overweight (25.0 – 29.9) | 11 (39.3) | 85 (45.7) | 0.75 (0.26 – 2.69) | 0.72 (0.23 – 2.69) |
| - Obesity (>=30) | 13 (46.4) | 76 (40.9) | 0.80 (0.28 – 2.86) | 1.03 (0.34 – 3.84) |
| Female | 10 (35.7) | 58 (30.9) | Ref. | Ref. |
| Male | 18 (64.3) | 130 (69.1) | 0.70 (0.33 – 1.59) | 0.65 (0.23 – 2.69) |
| Prague M length (cm) - 0 to 3 | 7 (25.0) | 80 (43.5) | Ref. | Ref. |
| - 4 or greater | 21 (75.0) | 104 (56.5) | 2.33 (1.04 – 5.93) | 2.34 (0.99 – 6.14) |
| Prague C length (cm) - 0 to 3 | 23 (82.1) | 169 (89.9) | Ref. | Ref. |
| - 4 or greater | 5 (17.9) | 19 (10.1) | 2.37 (0.80 – 5.75) | 1.86 (0.59 – 5.04) |
| Baseline grade – Low-grade dysplasia | 6 (21.4) | 69 (36.7) | Ref. | Ref. |
| - High-grade dysplasia | 21 (75.0) | 105 (55.9) | 2.46 (1.05 – 6.70) | 2.91 (1.21 – 8.15) |
| - Intramucosal adenocarcinoma | 1 (3.6) | 14 (7.4) | 0.80 (0.04 – 4.70) | 0.78 (0.04 – 5.08) |
BMI, body mass index.